This Week In AI Chips - Blockchain Meets Stocks With Onchain Tokenization Trends
NVIDIA Corporation NVDA | 0.00 |
Recent developments in the AI chip sector have seen a significant shift towards onchain tokenization of real-world assets, as evidenced by a new partnership between Bitget Wallet and Robinhood Crypto. This collaboration enables the integration of Robinhood Chain, an Ethereum Layer 2 solution, within Bitget Wallet, allowing users to trade Stock Tokens representing major companies like NVIDIA, Google, and Apple. The initiative demonstrates the growing trend of incorporating traditional finance into blockchain infrastructure by facilitating the settlement of tokenized stocks on a decentralized network. With this partnership, 90 million users worldwide can access a comprehensive ecosystem of onchain financial services, reflecting the broader move of financial industries towards blockchain technologies.
- NVIDIA (NasdaqGS:NVDA) last closed at $194.83 down 1.4%.
Elsewhere in the market, Kokusai Electric (TSE:6525) was trading firmly up 14.0% and finishing the session at ¥11,890, not far from its 52-week high. The company completed a share buyback of 211,200 shares, amounting to approximately ¥1,868.24 million, over the past month. In the meantime, Chongqing Genori Technology (SHSE:688797) lagged, down 19.1% to close at CN¥540.10.
Best AI Chip Stocks
- Broadcom (NasdaqGS:AVGO) ended the day at $360.45 down 2.4%.
- Advanced Micro Devices (NasdaqGS:AMD) closed at $517.82 down 4.3%.
- Micron Technology (NasdaqGS:MU) closed at $975.56 down 5.5%. This month, Micron entered a strategic agreement with General Motors to secure and collaborate on memory and storage technologies for next-gen vehicles.
Key Takeaways
- Explore the 139 names, such as Hangzhou Changchuan TechnologyLtd, Beijing YanDong MicroElectronic and Vanguard International Semiconductor, from our AI Chip Stocks screener here.
- Seeking Other Investments? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
